Gregory Russotti - 11 Apr 2023 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Chief Technology Officer
Signature
/s/ Michael Diem, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
11 Apr 2023
Net transactions value
$0
Form type
4
Filing time
13 Apr 2023, 17:29:42 UTC
Previous filing
06 Feb 2023
Next filing
11 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +318,750 $0.000000 318,750 11 Apr 2023 Common Stock 318,750 $3.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on April 11, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.